Campbell & CO Investment Adviser LLC Kura Oncology, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $179,009 - $313,866	13,339 New	13,339 $284,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $164,723 - $239,550	17,123 New	17,123 $181,000
Q2 2022 Aug 09, 2022	SELL	$10.71 - $18.33 $148,312 - $253,833	-13,848 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$11.78 - $16.98 $163,129 - $235,139	13,848 New	13,848 $223,000
Q4 2020 Feb 09, 2021	SELL	$29.0 - $41.62 $273,441 - $392,434	-9,429 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$16.3 - $30.64 $153,692 - $288,904	9,429 New	9,429 $289,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.